ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2020
Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy.
B Rodríguez-Sánchez et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it